In this issue:
Perioperative pembrolizumab combo improves survival in NSCLC
Neuromuscular training prevents against CIPN
DESTINY-CRC02: T-DXd active in HER2-positive CRC
DESTINY-Breast06: T-DXd prolongs PFS in HER2-low breast cancer
Immunotherapy-based TNT for pMMR/MSS locally advanced rectal cancer
Low MPR rate with neoadjuvant osimertinib in EGFR mutated NSCLC
Acupuncture may alleviate endocrine therapy-related hot flashes
Elucidating the optimal sequencing of TNT for non-metastatic rectal cancer
No survival benefit to primary tumour resection in CRC with unresectable metastases
Oxaliplatin-free regimens recommended for older patients with unresectable CRC
Please login below to download this issue (PDF)